The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder characterized pathologically by ubiquitinated TAR DNA binding protein (TDP-43) inclusions. The function of TDP-43 in the nervous system is uncertain, and a mechanistic role in neurodegeneration remains speculative. We identified neighboring mutations in a highly conserved region of TARDBP in sporadic and familial ALS cases. TARDBPM337V segregated with disease within one kindred and a genome-wide scan confirmed that linkage was restricted to chromosome 1p36, which contains the TARDBP locus. Mutant forms of TDP-43 fragmented in vitro more readily than wild type and, in vivo, caused neural apoptosis and developmental delay in the chick embryo. Our evidence suggests a pathophysiological link between TDP-43 and ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in TARDBP, which encodes the transactive response DNA binding protein 43 kDa (TDP-43), are the third most common cause of familial autosomal dominant ALS and account for rare cases of sporadic ALS [290–293].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [291]
In the citing paper
“while mutations in TARDBP (encoding TAR DNA- binding protein 43 [TDP43])306 and FUS (encoding the fused in sarcoma protein) have a lower frequency (<5%).307”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“emphasizing that microglia in the late stage accelerate disease progression.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“and mutations in TARDBP, the gene encoding TDP-43, have been identified in patients with ALS or FTD,306,333 indicating a mechanistic link between TDP-43 and ALS/FTD and also suggesting a common underlying mechanism”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“Reduced mutant levels in microglia did not have much effect on early disease progression, but substantially slowed it later on,306”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2
Hadano, S., Hand, C. K., Osuga, H., Yanagisawa, Y., Otomo, A., Devon, R. S., Miyamoto, N., Showguchi-Miyata, J., Okada, Y., Singaraja, R. R., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-166 · Cited by 676
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
Buratti, E. (2007) · Frontiers in bioscience · doi:10.2741/2727 · Cited by 493
Self-citationTDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail
Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S. G., Ayala, Y. M., & Baralle, F. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505557200 · Cited by 474
Self-citationCo-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Nakashima-Yasuda, H., Uryu, K., Robinson, J., Xie, S. X., Hurtig, H., Duda, J. E., Arnold, S. E., Siderowf, A., Grossman, M., Leverenz, J. B., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0261-2 · Cited by 468
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,011
Nishihira, Y., Tan, C.-F., Onodera, O., Toyoshima, Y., Yamada, M., Morita, T., Nishizawa, M., Kakita, A., & Takahashi, H. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0385-z · Cited by 187
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
Kawamata, H., & Manfredi, G. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.05.003 · Cited by 187
Brettschneider, J., Deerlin, V. M. V., Robinson, J. L., Kwong, L. K., Lee, E. B., Ali, Y., Safren, N., Monteiro, M. J., Toledo, J. B., Elman, L. B., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0970-z · Cited by 187
HDL and cognition in neurodegenerative disorders
Hottman, D. A., Chernick, D., Cheng, S., Wang, Z., & Li, L. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.015 · Cited by 188
Zhang, Y., Caulfield, T. R., Xu, Y., Gendron, T. F., Hubbard, J., Stetler, C. T., Sasaguri, H., Whitelaw, E. C., Cai, S., Lee, C. W., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt166 · Cited by 187
Autophagic and endo-lysosomal dysfunction in neurodegenerative disease
Malik, B. R., Maddison, D. C., Smith, G. A., & Peters, O. M. (2019) · Molecular Brain · doi:10.1186/s13041-019-0504-x · Cited by 187
Rossi, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.04.003 · Cited by 185
Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2
Damme, P. V., Veldink, J. H., van Blitterswijk, M., Corveleyn, A., van Vught, P. W. J., Thijs, V., Dubois, B., Matthijs, G., van den Berg, L. H., & Robberecht, W. (2011) · Neurology · doi:10.1212/wnl.0b013e31821f445b · Cited by 185
Frank, S. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909343106 · Cited by 185
Deletion of C9ORF72 Results in Motor Neuron Degeneration and Stress Sensitivity in C. elegans
Therrien, M., Rouleau, G. A., Dion, P. A., & Parker, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083450 · Cited by 183
Mackenzie, I. R. A., Ansorge, O., Strong, M., Bilbao, J., Zinman, L., Ang, L.-C., Baker, M., Stewart, H., Eisen, A., Rademakers, R., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0838-7 · Cited by 183
Verstraete, E., van den Heuvel, M. P., Veldink, J. H., Blanken, N., Mandl, R. C. W., Pol, H. E. H., & van den Berg, L. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013664 · Cited by 183
Covalent targeting of the vacuolar H+-ATPase activates autophagy via mTORC1 inhibition
Chung, C. Y., Shin, H. R., Berdan, C. A., Ford, B., Ward, C. C., Olzmann, J. A., Zoncu, R., & Nomura, D. K. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0308-4 · Cited by 182
Bentmann, E., Haass, C., & Dormann, D. (2013) · FEBS Journal · doi:10.1111/febs.12287 · Cited by 181
Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization
Pinarbasi, E. S., Çağatay, T., Fung, H. Y. J., Li, Y. C., Chook, Y. M., & Thomas, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-25008-4 · Cited by 180
The roles of hnRNP A2 / B1 in RNA biology and disease
Liu, Y., & Shi, S. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1612 · Cited by 186
Hall, C. E., Yao, Z., Choi, M., Tyzack, G. E., Serio, A., Luisier, R., Harley, J., Preza, E., Arber, C., Crisp, S. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.024 · Cited by 179
Phase separation-deficient TDP43 remains functional in splicing
Schmidt, H. B., Barreau, A., & Rohatgi, R. (2019) · Nature Communications · doi:10.1038/s41467-019-12740-2 · Cited by 182
Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains
Kametani, F., Obi, T., Shishido, T., Akatsu, H., Murayama, S., Saito, Y., Yoshida, M., & Hasegawa, M. (2016) · Scientific Reports · doi:10.1038/srep23281 · Cited by 176
Fratta, P., Sivakumar, P., Humphrey, J., Lo, K., Ricketts, T., Oliveira, H. M. D., Armas, J. M. B., Kalmár, B., Ule, A. M., Yu, Y., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798684 · Cited by 176
Self-citationMicroglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS
Xiao, S., Sanelli, T. R., Dib, S., Sheps, D., Findlater, J., Bilbao, J. M., Keith, J. L., Zinman, L. H., Rogaeva, E. A., & Robertson, J. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.02.013 · Cited by 175
Dissection of genetic factors associated with amyotrophic lateral sclerosis
Leblond, C. S., Kaneb, H., Dion, P. A., & Rouleau, G. A. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.013 · Cited by 175
Kapeli, K., Pratt, G. A., Vu, A. Q., Hutt, K. R., Martinez, F. J., Sundararaman, B., Batra, R., Freese, P., Lambert, N. J., Huelga, S. C., et al. (2016) · Nature Communications · doi:10.1038/ncomms12143 · Cited by 176
Salivary biomarkers for the diagnosis and monitoring of neurological diseases
Farah, R., Haraty, H., Salame, Z., Fares, Y., Ojcius, D. M., & Sadier, N. S. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.03.004 · Cited by 175
van Rheenen, W., Pulit, S. L., Dekker, A. M., Khleifat, A. A., Brands, W. J., Iacoangeli, A., Kenna, K. P., Kooyman, M., McLaughlin, R. L., Middelkoop, B. M., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0177-4 · Cited by 174
Self-citationHyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders
Zhang, W., Zhang, L., Liang, B., Schroeder, D. G., Zhang, Z., Cox, G. A., Li, Y., & Lin, D. (2016) · Nature Neuroscience · doi:10.1038/nn.4257 · Cited by 173
The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172
Molecular Neuropathology of TDP-43 Proteinopathies
Neumann, M. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10010232 · Cited by 172
Ticozzi, N., Vance, C. A., LeClerc, A. L., Keagle, P. J., Glass, J. D., McKenna‐Yasek, D., Sapp, P. C., Silani, V., Bosco, D. A., Shaw, C. E., et al. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31158 · Cited by 172
Self-citationHyttinen, J. M. T., Amadio, M., Viiri, J., Pascale, A., Salminen, A., & Kaarniranta, K. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.002 · Cited by 172
Chiò, A., Calvo, A., Mazzini, L., Cantello, R. M., Mora, G., Moglia, C., Corrado, L., D’Alfonso, S., Majounie, E., Renton, A. E., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182735d36 · Cited by 171
UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis
Williams, K. L., Warraich, S. T., Yang, S., Fifita, J. A., Fernando, R., Rouleau, G. A., Nicholson, G. A., & Blair, I. P. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.008 · Cited by 171
Self-citationWu, L.-S., Cheng, W.-C., & Shen, C. ‐. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359000 · Cited by 171
Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS
Estes, P. S., Boehringer, A. V., Zwick, R. A., Tang, J. E., Grigsby, B. M., & Zarnescu, D. C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr124 · Cited by 171
Mammana, S., Fagone, P., Cavalli, E., Basile, M. S., Petralia, M. C., Nicoletti, F., Bramanti, P., & Mazzon, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030831 · Cited by 171
Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum
Cruts, M., Gijselinck, I., Langenhove, T. V., van der Zee, J., & Broeckhoven, C. V. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.04.010 · Cited by 170
Misregulated RNA processing in amyotrophic lateral sclerosis
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Bennett, C. F., Cleveland, D. W., & Yeo, G. W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.059 · Cited by 169
In Vivo Formation of Vacuolated Multi-phase Compartments Lacking Membranes
Schmidt, H. B., & Rohatgi, R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.088 · Cited by 169
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
McGrowder, D. A., Miller, F. G., Vaz, K., Nwokocha, C. R., Wilson-Clarke, C. F., Anderson, M., Brown, J., Anderson-Jackson, L., Williams, L., Latore, L., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11020215 · Cited by 169
Gitcho, M. A., Bigio, E. H., Mishra, M., Johnson, N., Weıntraub, S., Mesulam, M. M., Rademakers, R., Chakraverty, S., Cruchaga, C., Morris, J. C., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0571-7 · Cited by 168
Campos‐Melo, D., Droppelmann, C. A., He, Z., Volkening, K., & Strong, M. J. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-26 · Cited by 169
The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes
Schwenk, B. M., Lang, C. M., Hogl, S., Tahirović, S., Orozco, D., Rentzsch, K., Lichtenthaler, S. F., Hoogenraad, C. C., Capell, A., Haass, C., et al. (2013) · The EMBO Journal · doi:10.1002/embj.201385857 · Cited by 168
RNA-binding proteins with prion-like domains in ALS and FTLD-U
Gitler, A. D., & Shorter, J. (2011) · Prion · doi:10.4161/pri.5.3.17230 · Cited by 167
TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
Arseni, D., Chen, R., Murzin, A. G., Peak‐Chew, S., Garringer, H. J., Newell, K. L., Kametani, F., Robinson, A., Vidal, R., Ghetti, B. F., et al. (2023) · Nature · doi:10.1038/s41586-023-06405-w · Cited by 167
Frontotemporal dementia and related disorders: Deciphering the enigma
Josephs, K. A. (2008) · Annals of Neurology · doi:10.1002/ana.21426 · Cited by 166
Dormann, D., Capell, A., Carlson, A. M., Shankaran, S. S., Rodde, R., Neumann, M., Kremmer, E., Matsuwaki, T., Yamanouchi, K., Nishihara, M., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06211.x · Cited by 166
Berson, A., Barbash, S., Shaltiel, G., Goll, Y., Hanin, G., Greenberg, D., Ketzef, M., Becker, A. J., Friedman, A., & Soreq, H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100995 · Cited by 166
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
Cruz-Haces, M., TANG, J. C. Y., Acosta, G., Fernandez, J., & Shi, R. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0088-2 · Cited by 166
Baxi, E. G., Thompson, T. G., Li, J., Kaye, J., Lim, R. G., Wu, J., Ramamoorthy, D., Lima, L. D. A., Vaibhav, V., Matlock, A. D., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-021-01006-0 · Cited by 166
TDP‐43 Redistribution is an Early Event in Sporadic Amyotrophic Lateral Sclerosis
Giordana, M. T., Piccinini, M., Grifoni, S., Marco, G. D., Vercellino, M., Magistrello, M., Pellerino, A., Buccinnà, B., Lupino, E., & RINAUDO, M. T. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00284.x · Cited by 166
The mutational landscape of a prion-like domain
Bolognesi, B., Faure, A. J., Seuma, M., Schmiedel, J. M., Tartaglia, G. G., & Lehner, B. (2019) · Nature Communications · doi:10.1038/s41467-019-12101-z · Cited by 165
Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum
Baradaran‐Heravi, Y., Broeckhoven, C. V., & van der Zee, J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104639 · Cited by 165
TDP-43 in aging and Alzheimer's disease - a review.
Wilson, A. C., Dugger, B. N., Dickson, D. W., & Wang, D.-S. (2011) · PubMed Central · Cited by 164
Liu, M.-L., Zang, T., & Zhang, C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.018 · Cited by 164
The clinical spectrum of sporadic and familial forms of frontotemporal dementia
Woollacott, I., & Rohrer, J. D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13654 · Cited by 163
Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort
Ticozzi, N., Silani, V., LeClerc, A. L., Keagle, P. J., Gellera, C., Ratti, A., Taroni, F., Kwiatkowski, T. J., McKenna‐Yasek, D., Sapp, P. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bbff05 · Cited by 163
From animal models to human disease: a genetic approach for personalized medicine in ALS
Picher‐Martel, V., Valdmanis, P. N., Gould, P. V., Julien, J., & Dupré, N. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0340-5 · Cited by 163
Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype
Mann, D. M. A., & Snowden, J. S. (2017) · Brain Pathology · doi:10.1111/bpa.12486 · Cited by 163
The era of cryptic exons: implications for ALS-FTD
Mehta, P. R., Brown, A., Ward, M. E., & Fratta, P. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00608-5 · Cited by 164
Disrupted neuronal trafficking in amyotrophic lateral sclerosis
Burk, K., & Pasterkamp, R. J. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01964-7 · Cited by 162
Rodent models of amyotrophic lateral sclerosis
McGoldrick, P., Joyce, P. I., Fisher, E., & Greensmith, L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.012 · Cited by 162
ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis
Kanekura, K., Suzuki, H., Aiso, S., & Matsuoka, M. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8054-3 · Cited by 162
FUS is Phosphorylated by DNA-PK and Accumulates in the Cytoplasm after DNA Damage
Deng, Q., Holler, C. J., Taylor, G., Hudson, K. F., Watkins, W., Gearing, M., Ito, D., Murray, M. E., Dickson, D. W., Seyfried, N. T., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0172-14.2014 · Cited by 161
A Computational Model of Motor Neuron Degeneration
Masson, G. L., Przedborski, S., & Abbott, L. F. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.001 · Cited by 161
Frontotemporal dementia and motor neurone disease: Overlapping clinic-pathological disorders
Lillo, P., & Hodges, J. R. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.03.005 · Cited by 161
Two German Kindreds With Familial Amyotrophic Lateral Sclerosis Due to TARDBP Mutations
Kühnlein, P., Sperfeld, A., Vanmassenhove, B., Deerlin, V. M. V., Lee, V. M. ‐., Trojanowski, J. Q., Kretzschmar, H. A., Ludolph, A. C., & Neumann, M. (2008) · Archives of Neurology · doi:10.1001/archneur.65.9.1185 · Cited by 161
Interaction with Polyglutamine Aggregates Reveals a Q/N-rich Domain in TDP-43
Fuentealba, R. A., Udan-Johns, M., Bell, S., Wegorzewska, I., Shao, J., Diamond, M. I., Weihl, C. C., & Baloh, R. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125039 · Cited by 161
Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand
Ramesh, N., & Pandey, U. B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00263 · Cited by 161
SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS
Hayashi, Y., Homma, K., & Ichijo, H. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.10.006 · Cited by 161
Jiang, L.-L., Che, M., Zhao, J., Zhou, C.-J., Xie, M.-Y., Li, H.-Y., He, J.-H., & Hu, H.-Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463828 · Cited by 160
Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones
Udan-Johns, M., Bengoechea, R., Bell, S., Shao, J., Diamond, M. I., True, H. L., Weihl, C. C., & Baloh, R. H. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt408 · Cited by 160
Diaper, D. C., Adachi, Y., Sutcliffe, B., Humphrey, D. M., Elliott, C. J. H., Stepto, A., Ludlow, Z. N., Broeck, L. V., Callaerts, P., Dermaut, B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt005 · Cited by 160
Self-citationEpidemiology of amyotrophic lateral sclerosis: A review of literature
Couratier, P., Corcia, P., Lautrette, G., Nicol, M., Preux, P., & Marin, B. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.11.002 · Cited by 160
Welander distal myopathy is caused by a mutation in the RNA‐binding protein TIA1
Hackman, P., Sarparanta, J., Lehtinen, S., Vihola, A., Evilä, A., Jonson, P. H., Luque, H., Kere, J., Screen, M., Chinnery, P. F., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23831 · Cited by 159
Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS
Lee, J.-H., Hyeon, S. J., Im, H., Ryu, H., Kim, Y., & Ryu, H. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.5.233 · Cited by 160
De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis
DeJesus‐Hernandez, M., Kocerha, J., Finch, N. A., Crook, R., Baker, M. C., Desaro, P., Johnston, A., Rutherford, N. J., Wojtas, A., Kennelly, K. D., et al. (2010) · Human Mutation · doi:10.1002/humu.21241 · Cited by 158
Soon, C. P. W., Donnelly, P. S., Turner, B. J., Hung, L. W., Crouch, P. J., Sherratt, N. A., Tan, J., Lim, N. K.-H., Lam, L. Q., Bica, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274407 · Cited by 158
UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration
Groen, E. J. N., & Gillingwater, T. H. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.08.003 · Cited by 157
Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
Freischmidt, A., Müller, K., Ludolph, A. C., & Weishaupt, J. H. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-42 · Cited by 157
Activity-dependent FUS dysregulation disrupts synaptic homeostasis
Sephton, C. F., Tang, A. A., Kulkarni, A., West, J. D., Brooks, M., Stubblefield, J. J., Liu, Y., Zhang, M. Q., Green, C. B., Huber, K. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406162111 · Cited by 156
Coyne, A. N., Siddegowda, B. B., Estes, P. S., Johannesmeyer, J., Kovalik, T., Daniel, S. G., Pearson, A., Bowser, R. P., & Zarnescu, D. C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2526-14.2014 · Cited by 156
Marangi, G., & Traynor, B. J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.009 · Cited by 155
Frontotemporal Dementia: Implications for Understanding Alzheimer DiseasePreprint
Goedert, M., Ghetti, B. F., & Spillantini, M. G. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006254 · Cited by 156
Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy
Laird, A. S., Hoecke, A. V., Muynck, L. D., Timmers, M., Bosch, L. V. D., Damme, P. V., & Robberecht, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013368 · Cited by 154
Ince, P. G., Highley, J. R., Kirby, J., Wharton, S. B., Takahashi, H., Strong, M. J., & Shaw, P. J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0913-0 · Cited by 154
Towards a TDP-43-Based Biomarker for ALS and FTLD
Feneberg, E., Gray, E., Ansorge, O., Talbot, K., & Turner, M. R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0947-6 · Cited by 154
The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis
Strong, M. J. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802372371 · Cited by 154
Gerstberger, S. C., Hafner, M., Ascano, M., & Tuschl, T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_1 · Cited by 154
ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN
Groen, E. J. N., Fumoto, K., Blokhuis, A. M., Engelen-Lee, J.-Y., Zhou, Y., van den Heuvel, D. M. A., Koppers, M., van Diggelen, F., van Heest, J., Demmers, J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt222 · Cited by 153
Song, S., Miranda, C. J., Braun, L., Meyer, K., Frakes, A. E., Ferraiuolo, L., Likhite, S. B., Bevan, A. K., Foust, K. D., McConnell, M. J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4052 · Cited by 153
The N-terminal dimerization is required for TDP-43 splicing activity
Jiang, L., Xue, W., Hong, J.-Y., Zhang, J.-T., Li, M., Yu, S., He, J., & Hu, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-06263-3 · Cited by 153
Structural Insights Into TDP-43 and Effects of Post-translational Modifications
François‐Moutal, L., Perez‐Miller, S., Scott, D. D., Miranda, V. G., Mollasalehi, N., & Khanna, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00301 · Cited by 153
SQSTM1 mutations – Bridging Paget disease of bone and ALS/FTLD
Rea, S. L., Majcher, V., Searle, M. S., & Layfield, R. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.01.020 · Cited by 152
Crugnola, V., Lamperti, C., Lucchini, V., Ronchi, D., Peverelli, L., Prelle, A. C., Sciacco, M., Bordoni, A., Fassone, E., Fortunato, F., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.128 · Cited by 152
Invited Review: The role of prion‐like mechanisms in neurodegenerative diseases
Jaunmuktane, Z., & Brandner, S. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12592 · Cited by 153
On-chip 3D neuromuscular model for drug screening and precision medicine in neuromuscular disease
Osaki, T., Uzel, S. G. M., & Kamm, R. D. (2020) · Nature Protocols · doi:10.1038/s41596-019-0248-1 · Cited by 152
Self-assembled FUS binds active chromatin and regulates gene transcription
Yang, L., Gál, J., Chen, J., & Zhu, H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414004111 · Cited by 151
Pathogenesis of FUS-associated ALS and FTD: insights from rodent models
Nolan, M., Talbot, K., & Ansorge, O. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0358-8 · Cited by 151
Molecular and Cellular Mechanisms Affected in ALS
Gall, L. L., Anakor, E., Connolly, O., Vijayakumar, U. G., Duddy, W. J., & Duguez, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030101 · Cited by 152
Metadata
- Authors
- Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., Baralle, F., de Belleroche, J., Mitchell, J. D., Leigh, P. N., Al-Chalabi, A., Miller, C. C., Nicholson, G., & Shaw, C. E.
- Affiliations
- The University of Sydney (AU)
- Department of Clinical Neuroscience, King's College London, Medical Research Council (MRC) Centre for Neurodegeneration Research, and Institute of Psychiatry, London, SE5 8AF, UK.
- Corresponding author
- Sreedharan, Jemeen
- Blair, Ian P.
- Tripathi, Vineeta B.
- Nicholson, Garth
- Shaw, Christopher E.
- ORCID
- Venue
- Science
- Published
- 2008-03-21
- Volume
- 319
- Issue
- 5870
- Pages
- 1668-1672
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7116650
- OpenAlex
- W1619082318
- Cited by
- 2,630
- References
- 29
- Citations by year
- 2026: 73 · 2025: 88 · 2024: 104 · 2023: 141 · 2022: 149 · 2021: 141 · 2020: 149 · 2019: 121 · 2018: 147 · 2017: 117 · 2016: 156 · 2015: 154 · 2014: 167 · 2013: 168 · 2012: 192
- FWCI
- 119.36
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Funders
- Wellcome Trust (076671)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, TDP-43, TARDBP, familial ALS, sporadic ALS, TDP-43 mutations, chromosome 1p36, genetic linkage, ubiquitinated inclusions, neurodegeneration, neuronal apoptosis, protein fragmentation
- MeSH terms
- Adult, Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Chick Embryo, Chromosomes, Human, Pair 1, Cricetulus, DNA-Binding Proteins, Female, Cricetinae, Humans, Male, Middle Aged, Molecular Sequence Data, Neurons, CHO Cells, Apoptosis, Microsatellite Repeats, Amino Acid Substitution, Mutation, Missense, Embryonic Development, Mutant Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review